S

Southern Neurology | Sydney, Australia

Research site

(Unclaimed)

Location

2/19 Kensington Street, Kogarah 2217, Sydney, New South Wales, Australia

Site insights

Top conditions

Top treatments

SHR-1707

XEN1101

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE2)

The X-TOLE2 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and toler...

Enrolling

Focal Onset Seizures

Drug: XEN1101

Drug: Placebo

A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis (NIMBLE)

This study is researching an experimental combination treatment with pozelimab and cemdisiran, and cemdisiran monotherapy. The study is focused on pa...

Enrolling

Generalized Myasthenia Gravis

Drug: Pozelimab

Drug: Pozelimab + Cemdisiran

A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-1707 in patients with mild cognitive impairment (MCI) due to Alzhe...

Active, not recruiting

Alzheimer's Disease (AD)

Drug: SHR-1707 injection

Drug: Placebo

Trial sponsors

A

X

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms